EUVIMEDEUVIMED entdecken
Crossref

Plasma proteomics biomarkers for predicting anti‐tuberculosis drug‐induced liver injury: A comprehensive assessment

Ming-Gui Wang iD, Meng-Meng Zhang, Quan-Xian Liu iD, Jian-Qing He

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Ming-Gui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Antitubercular Agents, Chemical and Drug Induced Liver Injury, Proteomics, Blood Proteins. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to identify predictive plasma protein biomarkers for anti‐tuberculosis drug‐induced liver injury (ATB‐DILI) and develop machine learning models for pre‐treatment risk stratification.

Methods

In this retrospective nested case–control study, proteomic profiling of pre‐treatment plasma from 24 patients (12 ATB‐DILI, 12 controls) identified differentially expressed proteins, which were validated by ELISA in an independent cohort (35 ATB‐DILI, 37 controls). Multiple machine learning algorithms were implemented to develop clinical prediction models and evaluate the prognostic value of the identified protein biomarkers.

Results

Proteomic analysis of pre‐treatment samples from the exploratory cohort identified five significantly differentially expressed proteins: antithrombin III, apolipoprotein D, carboxypeptidase B2, Chromogranin‐A, and Retinol‐binding protein 4. These proteins are functionally implicated in inflammatory responses, oxidative stress, and drug metabolism pathways. Validation using baseline plasma from an independent cohort confirmed consistent expression patterns for all five proteins ( p < 0.01), with directional changes matching the discovery phase findings. The random forest model, built on these pre‐treatment biomarkers, demonstrated robust predictive performance in the test set (AUC = 0.94, sensitivity = 90.0%, specificity = 90.0%, accuracy = 0.90). Importantly, consensus across multiple machine learning approaches (GBDT, SVM, GBM, etc.) confirmed predictive stability and generalizability of this protein signature (inter‐model AUC range: 0.85–0.96).

Conclusion

This study has successfully identified five pre‐treatment plasma protein signature that, when incorporated into machine learning models, may enable the prediction of ATB‐DILI risk, offering potential for early intervention in tuberculosis therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsChemical and Drug Induced Liver InjuryProteomicsBlood ProteinsHumansBiomarkersFemaleMaleCase-Control StudiesRetrospective StudiesMiddle AgedAdultMachine LearningPredictive Value of TestsPredictive Learning ModelsRisk Assessment

Stichwörter der Autor:innen

biomarkerdrug‐induced liver injuryproteomicsrandom forest modeltuberculosis

Substanzen

Antitubercular AgentsBiomarkersBlood Proteins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.
  • Department of Respiratory and Critical Care Medicine, Genertec 363 Hospital, Chengdu, China.

ORCID-Profile: Ming-Gui Wang, Quan-Xian Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, M. G., Zhang, M. M., Liu, Q. X., & He, J. Q. (2026). Plasma proteomics biomarkers for predicting anti‐tuberculosis drug‐induced liver injury: A comprehensive assessment. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70446

Vancouver

Wang MG, Zhang MM, Liu QX, He JQ. Plasma proteomics biomarkers for predicting anti‐tuberculosis drug‐induced liver injury: A comprehensive assessment. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70446

BibTeX
@article{Wang2026,
  author = {Wang, Ming-Gui and Zhang, Meng-Meng and Liu, Quan-Xian and He, Jian-Qing},
  title = {Plasma proteomics biomarkers for predicting anti‐tuberculosis drug‐induced liver injury: A comprehensive assessment},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70446}
}
Kostenlos starten →